ASHLEY MACCARELLO: Open Payments
NPI 1942768932 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 40 payments from 17 companies in 2025. Trend: 2023 $1,020 · 2024 $410 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $168 |
| Novo Nordisk Inc | 6 | $125 |
| Hologic Sales and Service, LLC | 3 | $93 |
| PFIZER INC. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Corium, LLC | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| Lundbeck LLC | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Medicure Pharma Inc. | 1 | $38 |
Products named: CAPLYTA, APTIMA, Ozempic, AIRSUPRA, Azstarys, TRELEGY ELLIPTA, REXULTI, ELIQUIS.
Industry payments across FL — which companies pay providers there.
